$195.85
+0.50%Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Asset-light with strong cash conversion: Low capital requirements combined with efficient cash generation creates significant shareholder value through dividends, buybacks, or strategic investments.
CAH โข NYSE
| Cardinal Health, Inc. Cash Flow Statement | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | Jun 2008 | Jun 2007 | Jun 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
1.6B | 853M | 331M | -933M | 612M | -3.7B | 1.4B | 259M | 1.3B | 1.4B | 1.2B | 1.2B | 335M | 1.1B | 966M | 587M | 758.2M | 847.2M | 1.9B | 1B | |
790M | 710M | 692M | 723M | 783M | 913M | 1B | 1B | 717M | 641M | 451M | 459M | 397M | 325M | 313.3M | 254.4M | 399.4M | 381.3M | 322.1M | 392.7M | |
243M | -104M | -40M | 7M | 496M | -961M | -83M | -1B | 291M | 87M | 219M | 26M | 21M | 158M | 128M | 120M | 69.5M | 26.9M | 11.7M | -5.7M | |
244M | 121M | 96M | 0.0 | 89M | 90M | 82M | 85M | 96M | 111M | 110M | 96M | 93M | 85M | 79.5M | 99.5M | 122.8M | 122.3M | 138.1M | 237.3M | |
74M | 672M | 1.3B | 5.7B | 160M | -450M | -397M | 1.5B | 53M | 78M | 96M | 25M | 890M | -28M | -46M | 198M | 617.9M | 461.2M | -605.5M | 671.8M | |
(444M) | (191M) | (156M) | (0.0) | (273M) | (368M) | (311M) | (425M) | (686M) | (635M) | (529M) | (632M) | (899M) | (513M) | (588M) | (514M) | (429.3M) | (116M) | (0.0) | (0.0) | |
-523M | 1.5B | 457M | -2.3B | 289M | 6.1B | 755M | 907M | -1.3B | 623M | 452M | 755M | -9M | -434M | -46M | 875M | -357.4M | -121.5M | -436.3M | 157M | |
2.4B | 3.8B | 2.8B | 3.1B | 2.4B | 2B | 2.7B | 2.8B | 1.2B | 3B | 2.5B | 2.5B | 1.7B | 1.2B | 1.4B | 2.1B | 1.6B | 1.5B | 1.2B | 2.1B | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-547M | -511M | -481M | -387M | -400M | -375M | -328M | -384M | -387M | -465M | -300M | -249M | -195M | -263M | -291.3M | -255.8M | -533.4M | -376.1M | -357.4M | -443.2M | |
-5.3B | -1.2B | -10M | (901M) | -3M | (0.0) | -82M | -6.1B | -132M | -3.6B | -503M | -519M | -2.2B | -174M | -2.3B | -32M | -128.6M | -4.7M | -1.6B | -362.2M | |
(0.0) | -550M | (0.0) | -78M | -22M | -20M | -18M | -9M | -194M | -200M | -342M | -129M | -12M | -35M | -156M | (0.0) | (0.0) | (0.0) | (0.0) | -398.6M | |
202M | 384M | 29M | 100M | 47M | 886M | 3M | 65M | 305M | 186M | 243M | 47M | 71M | 92M | 716M | 271M | 0.0 | 132M | 366.5M | 0.0 | |
-10M | 18M | 8M | 31M | 0.0 | 2M | 763M | 862M | 3M | 13M | 53M | 0.0 | 0.0 | 0.0 | 3M | 148M | -6M | -697.9M | 3.2B | -86.6M | |
-5.6B | -1.8B | -454M | (567M) | -378M | (493M) | (338M) | -5.6B | -405M | -4.1B | -849M | -850M | -2.4B | -377M | -2B | (127.1M) | -542.9M | -726.4M | (1.5B) | -1.2B | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-765M | -750M | -2B | -1B | -200M | -350M | -600M | -550M | -600M | -651M | -1B | -673M | -329M | -408M | -207M | -190M | 39.2M | -953.7M | -3.1B | -1.3B | |
3.2B | 356M | -579M | -885M | -570M | -1.4B | -1.1B | -1B | 4.9B | 20M | 1.4B | 112M | 980M | 258M | 312M | -1.5B | -304.2M | 296.4M | 630.5M | 299.8M | |
-494M | -499M | -525M | -559M | -573M | -569M | -577M | -581M | -577M | -512M | -460M | -415M | -353M | -300M | -274.2M | -253.1M | -200.4M | -173.1M | -144.4M | -101.8M | |
-765M | -750M | -2B | -1B | -200M | -350M | -600M | -550M | -600M | -651M | -1B | -673M | -450M | -450M | -270M | -230M | (0.0) | -1.2B | -3.7B | -1.5B | |
-13M | 46M | 53M | -19M | 26M | 120M | -14M | -144M | 59M | 4M | 117M | 266M | -23M | -4M | -23.4M | 1.2B | -2.8M | 27.2M | -15.5M | 28.9M | |
2B | -847M | -3.1B | -2.5B | -1.3B | -2.2B | -2.3B | -2.3B | 3.7B | -1.1B | 60M | -710M | 275M | -454M | -192.6M | -727.5M | -468.2M | -803.2M | -2.6B | -1B | |
CASH FLOW SUMMARY | ||||||||||||||||||||
-3M | -9M | -8M | 84M | -98M | -13M | 1M | 4M | -2M | -12M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
-1.3B | 1.1B | -669M | 1.3B | 636M | 240M | 768M | -5.1B | 4.5B | -2.3B | 1.8B | 964M | -373M | 345M | -826M | 1.5B | 556.2M | -17.5M | 121.5M | -79.1M | |
5.1B | 4.1B | 4.7B | 3.4B | 2.8B | 2.5B | 1.8B | 6.9B | 2.4B | 4.6B | 2.9B | 1.9B | 2.3B | 1.9B | 2.8B | 1.2B | 1.3B | 1.3B | 1.2B | 1.4B | |
3.9B | 5.1B | 4.1B | 4.7B | 3.4B | 2.8B | 2.5B | 1.8B | 6.9B | 2.4B | 4.6B | 2.9B | 1.9B | 2.3B | 1.9B | 2.8B | 1.8B | 1.3B | 1.3B | 1.3B | |
1.9B | 3.3B | 2.4B | 2.7B | 2B | 1.6B | 2.4B | 2.4B | 797M | 2.5B | 2.2B | 2.3B | 1.5B | 913M | 1.1B | 1.9B | 1B | 1.1B | 865.7M | 1.7B |
CAH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 23, 2026 | March 17, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 02, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | February 05, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 13, 2026 | January 13, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 05, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | October 30, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 30, 2025 | October 30, 2025 | 2025 |
Continue your CAH research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.